<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> exposure to <z:chebi fb="56" ids="16716">benzene</z:chebi> can result in transient hematotoxicity (<z:chebi fb="56" ids="16716">benzene</z:chebi> poisoning, BP) or persistent bone marrow pathology including <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and/or <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We recently described a persistent bone marrow <z:mpath ids='MPATH_589'>dysplasia</z:mpath> with unique dysplastic and inflammatory features developing in individuals previously exposed to <z:chebi fb="56" ids="16716">benzene</z:chebi> (BID) [Irons RD, Lv L, Gross SA, Ye X, Bao L, Wang XQ, et al </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> exposure to <z:chebi fb="56" ids="16716">benzene</z:chebi> results in a unique form of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>Leuk Res 2005;29:1371-80] </plain></SENT>
<SENT sid="4" pm="."><plain>In this study we investigated the association of single nucleotide polymorphisms (SNP) (-863 (C--&gt;A), -857 (C--&gt;T), -308 (G--&gt;A), -238 (G--&gt;A)) in the promoter region of the cytokine, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-alpha) on the development of BP, persistent BID and de novo <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) in 394 individuals </plain></SENT>
<SENT sid="5" pm="."><plain>Only the -238 (G--&gt;A) polymorphism was significantly associated with the development of BID (odds ratio (OR)=7.4; 95% C.I </plain></SENT>
<SENT sid="6" pm="."><plain>1.23-44.7) and was specific for BID and not de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or BP </plain></SENT>
<SENT sid="7" pm="."><plain>These findings are consistent with a role for <z:mp ids='MP_0001845'>inflammation</z:mp> in the development of BID and suggest that cell-specific alterations in TNF-alpha expression may promote clonal selection in the evolution of neoplastic hematopoietic disease </plain></SENT>
</text></document>